Physician

Abigail Sagar Plonk, PA-C

According to 2025 Medicare claims, Abigail Plonk, PA-C (NPI: 1265456420) practices physician assistant in the Winston-Salem, NC market, with the plurality of this provider's patient population coming from Forsyth, NC. This provider's primary affiliated billing organization is WESTGATE DERMATOLOGY AND LASER CENTER, P.A. (NPI: 1821240995; TIN: 263467563) and primary practice location at 27106-4851.

Plonk's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 177 traditional Medicare patients, billed 736 HCPCS/CPT codes, and received $25,465 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 626 prescription claims across 235 beneficiaries totaling $502,670 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 64 records totaling $1,292. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $3,097 and ending at $25,465. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $7,539 to $502,670. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$33K$67K2015 Medicare payment: $3,097 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,923 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $17,233 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $37,951 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $66,586 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $19,283 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $19,131 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $25,382 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $21,623 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $25,465 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20156078$3,097
20162744$1,923
2017109601$17,233
20182742,121$37,951
20193734,259$66,586
2020185661$19,283
2021118505$19,131
2022172644$25,382
2023137617$21,623
2024177736$25,465

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$251K$503K2015 Drug cost: $7,539 (USD; Tot_Drug_Cst)2016 Drug cost: $3,572 (USD; Tot_Drug_Cst)2017 Drug cost: $595 (USD; Tot_Drug_Cst)2018 Drug cost: $22,730 (USD; Tot_Drug_Cst)2019 Drug cost: $34,500 (USD; Tot_Drug_Cst)2020 Drug cost: $63,324 (USD; Tot_Drug_Cst)2021 Drug cost: $95,370 (USD; Tot_Drug_Cst)2022 Drug cost: $31,202 (USD; Tot_Drug_Cst)2023 Drug cost: $391,670 (USD; Tot_Drug_Cst)2024 Drug cost: $502,670 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015112236$7,539
20164992$3,572
20171518$595
2018118174$22,730
2019136214$34,500
202065121$63,324
2021111283$95,370
2022204488$31,202
2023175546$391,670
2024235626$502,670

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths4858$56
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more112141$49
11102Biopsy of related skin growth, first growth6981$46
17000Destruction of precancer skin growth, 1 growth6984$23
17003Destruction of precancer skin growth, 2-14 growths43228$4

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Humira(Cf) PenAdalimumab21588$337,364
Dupixent PenDupilumab35966$140,557
Clobetasol PropionateClobetasol Propionate671,867$2,847
PimecrolimusPimecrolimus13334$1,958
MetronidazoleMetronidazole21582$1,533

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.64$1,292ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Abigail Sagar Plonk, PA-C?

Tedicare shows public-source Medicare data for Abigail Sagar Plonk, PA-C (NPI 1265456420), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abigail Sagar Plonk, PA-C have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Abigail Sagar Plonk, PA-C?

Abigail Sagar Plonk, PA-C is linked to WESTGATE DERMATOLOGY AND LASER CENTER, P.A. (billing NPI 1821240995) in the available physician profile data.

Does Abigail Sagar Plonk, PA-C have Open Payments data?

Abigail Sagar Plonk, PA-C has 64 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.